News Releases

Date	Title
Sep 21, 2023	Cue Health Adopts Limited-Duration Shareholder Rights Plan
Aug 23, 2023	Cue Health to Present at Upcoming Investor Conferences
Aug 09, 2023	Cue Health Reports Second Quarter 2023 Financial Results
Aug 03, 2023	Cue Health Awarded New $28 Million Federal Contract to Develop Flu A/B, RSV, COVID-19 Molecular Multiplex Test for Both Over-the-Counter and Point-of-Care Use
Jul 26, 2023	Cue Health to Announce Second Quarter 2023 Financial Results
Jun 06, 2023	Cue Health Achieves Groundbreaking Milestone with FDA: First Company to Receive De Novo Authorization for a COVID-19 Home Use Test
May 31, 2023	Cue Health to Present at the Goldman Sachs 44th Annual Global Healthcare Conference
May 10, 2023	Cue Health Reports First Quarter 2023 Financial Results
May 09, 2023	Cue Health Makes De Novo Submission to FDA for Full Clearance of its Cue® RSV Molecular Test
May 08, 2023	Cue Health Launches Pharmacy Offering to Empower Individuals to Manage Common Health and Wellness Needs from Home

Shareholder Tools